Long-term oncologic outcomes of neoadjuvant concurrent chemoradiotherapy with capecitabine and radical surgery in locally advanced rectal cancer: 10-year experiences at a single institution

Схожие документы

• Additional 4-week capecitabine during the resting periods after 6-week neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: long-term oncologic outcomes
  по: Park, Sang Woo, et al.
  Опубликовано: (2018)
• A Phase II Study of Additional Four-Week Chemotherapy With Capecitabine During the Resting Periods After Six-Week Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
  по: Lee, Kyung Ha, et al.
  Опубликовано: (2013)
• Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
  по: Wanghua Chen, et al.
  Опубликовано: (2018-08-01)
• Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
  по: Chen, Wanghua, et al.
  Опубликовано: (2018)
• Effect of Neoadjuvant Chemoradiotherapy with Capecitabine versus Fluorouracil for Locally Advanced Rectal Cancer: A Meta-Analysis
  по: Liu, Guo-Chen, et al.
  Опубликовано: (2016)